Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (461-470 of 535) with videos related to

Pageof 54
Sort By:
Nature Communications|January 2, 2025
Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in IndonesiaTodia P Setiabudiawan, Lika Apriani, Ayesha J Verrall, et al.
Nature|June 9, 2021
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter, Jingyou Yu, Jinyan Liu, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Database : the Journal of Biological Databases and Curation|February 10, 2023
Coronavirus Immunotherapeutic Consortium DatabaseJarjapu Mahita, Brendan Ha, Anais Gambiez, et al.
Science Translational Medicine|July 29, 2020
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccinationTodd J Suscovich, Jonathan K Fallon, Jishnu Das, et al.
Blood Advances|June 5, 2025
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemiaAndrew R Branagan, Clifton Mo, Matthew Lei, et al.
The Journal of Infectious Diseases|July 17, 2018
Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona IsolateThomas Luke, Richard S Bennett, Dawn M Gerhardt, et al.
Cell Host & Microbe|January 11, 2019
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus ProtectionAnna Z Wec, Zachary A Bornholdt, Shihua He, et al.
Cell|November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeysDan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
The Lancet. HIV|February 21, 2020
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)Kathryn E Stephenson, Frank Wegmann, Frank Tomaka, et al.
Pageof 54

Showing results (461-470 of 535) with videos related to

Sort By:
Pageof 54
Nature Communications|January 2, 2025
Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in IndonesiaTodia P Setiabudiawan, Lika Apriani, Ayesha J Verrall, et al.
Nature|June 9, 2021
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humansGalit Alter, Jingyou Yu, Jinyan Liu, et al.
Cell|August 20, 2021
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egressLauren E Williamson, Kristen M Reeder, Kevin Bailey, et al.
Database : the Journal of Biological Databases and Curation|February 10, 2023
Coronavirus Immunotherapeutic Consortium DatabaseJarjapu Mahita, Brendan Ha, Anais Gambiez, et al.
Science Translational Medicine|July 29, 2020
Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccinationTodd J Suscovich, Jonathan K Fallon, Jishnu Das, et al.
Blood Advances|June 5, 2025
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemiaAndrew R Branagan, Clifton Mo, Matthew Lei, et al.
The Journal of Infectious Diseases|July 17, 2018
Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona IsolateThomas Luke, Richard S Bennett, Dawn M Gerhardt, et al.
Cell Host & Microbe|January 11, 2019
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus ProtectionAnna Z Wec, Zachary A Bornholdt, Shihua He, et al.
Cell|November 19, 2013
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeysDan H Barouch, Kathryn E Stephenson, Erica N Borducchi, et al.
The Lancet. HIV|February 21, 2020
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22)Kathryn E Stephenson, Frank Wegmann, Frank Tomaka, et al.
Pageof 54